Carnegie Investment Counsel Boosts Stock Holdings in Milestone Scientific Inc. (NYSE:MLSS)

Carnegie Investment Counsel raised its holdings in Milestone Scientific Inc. (NYSE:MLSS) by 18.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 172,609 shares of the company’s stock after purchasing an additional 27,412 shares during the quarter. Carnegie Investment Counsel owned 0.22% of Milestone Scientific worth $166,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MLSS. World Investment Advisors LLC acquired a new position in shares of Milestone Scientific during the 3rd quarter worth $91,000. Y Intercept Hong Kong Ltd purchased a new stake in Milestone Scientific during the third quarter worth about $48,000. Finally, Geode Capital Management LLC grew its position in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares during the period. Institutional investors and hedge funds own 5.79% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. StockNews.com started coverage on shares of Milestone Scientific in a research report on Monday, January 13th. They set a “hold” rating for the company. Benchmark reaffirmed a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Insider Buying and Selling at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the transaction, the director now owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 24.75% of the company’s stock.

Milestone Scientific Stock Performance

Shares of NYSE MLSS opened at $1.18 on Monday. The company’s 50-day moving average price is $0.90 and its 200 day moving average price is $0.91. Milestone Scientific Inc. has a 52 week low of $0.54 and a 52 week high of $1.27. The stock has a market cap of $91.91 million, a price-to-earnings ratio of -16.85 and a beta of 1.10.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.